Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 9 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 128 business days late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays.
The 12 most recent Form 4 transactions.
| Jun 5 | ARQT | Arcutis Biotherapeutics,… | AGRANT◆ | 16,667 | — | — | — | Open the original filing on SEC.gov |
| Jun 5 | ARQT | Arcutis Biotherapeutics,… | AGRANT | 5,778 | — | — | +143.7% | Open the original filing on SEC.gov |
| Feb 21 | IKT | Inhibikase Therapeutics,… | DTOISS | 19,089 | — | — | -33.3% | Open the original filing on SEC.gov |
| Dec 4, 2025 | ARQT | Arcutis Biotherapeutics,… | AGRANT◆ | 6,177 | — | — | — | Open the original filing on SEC.gov |
| Dec 4, 2025 | ARQT | Arcutis Biotherapeutics,… | AGRANT◆ | 16,502 | — | — | — | Open the original filing on SEC.gov |
| Dec 4, 2025 | ARQT | Arcutis Biotherapeutics,… | AGRANT | 2,021 | — | — | +101.0% | Open the original filing on SEC.gov |
| Jun 30, 2025 | IKT | Inhibikase Therapeutics,… | AGRANT◆ | 108,176 | — | — | — | Open the original filing on SEC.gov |
| Jun 18, 2025 | DMRA | Damora Therapeutics, Inc. | AGRANT◆ | 720 | — | — | — | Open the original filing on SEC.gov |
| May 21, 2025 | ZURA | Zura Bio Ltd | AGRANT◆ | 51,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 21, 2025 | IKT | Inhibikase Therapeutics,… | AGRANT | 57,265 | — | — | — | Open the original filing on SEC.gov |